Top

Published in:

Open Access 01-12-2014 | Review

Arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome: from molecular genetics to clinical features

Authors: Yaoyao Zhou, Junfeng Zhang

Published in: Italian Journal of Pediatrics | Issue 1/2014

Abstract

Arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome is a rare but fatal autosomal recessive multisystem disorder caused by mutations in the VPS33B or VIPAR gene. The classical presentation of ARC includes congenital joint contractures, renal tubular dysfunction, and cholestasis. Additional features include ichthyosis, central nervous system malformation, platelet anomalies, and severe failure to thrive. Diagnosis of ARC syndrome relies on clinical features, organ biopsy, and mutational analysis. However, no specific treatment currently exists for this syndrome.

Conclusion

This is an overview of the latest knowledge regarding the genetic features and clinical manifestations of ARC syndrome. Greater awareness and understanding of this syndrome should allow more timely intervention with potential for improving long-term outcome.

Available only for authorised users

Lutz-Richner AR, Landolt RF: Familiare Gallengansmissbildungen mit tubularer Neireninsurfizienz. Helv Paediatr Acta. 1973, 28: 1-12.

Taha D, Khider A, Cullinane AR, Gissen P: A novel VPS33B mutation in an ARC syndrome patient presenting with osteopenia and fractures at birth. Am J Med Genet A. 2007, 143A (23): 2835-2837. 10.1002/ajmg.a.32051.CrossRefPubMed

Gissen P, Tee L, Johnson CA, Genin E, Caliebe A, Chitayat D, Clericuzio C, Denecke J, Di Rocco M, Fischler B, FitzPatrick D, Garcia-Cazorla A, Guyot D, Jacquemont S, Koletzko S, Leheup B, Mandel H, Sanseverino MT, Houwen RH, McKiernan PJ, Kelly DA, Maher ER: Clinical and molecular genetic features of ARC syndrome. Hum Genet. 2006, 120 (3): 396-409. 10.1007/s00439-006-0232-z.CrossRefPubMed

Abdullah MA, Al-Hasnan Z, Okamoto E, Abomelha AM: Arthrogryposis, renal dysfunction and cholestasis syndrome. Saudi Med J. 2000, 21 (3): 297-299.PubMed

Gissen P, Johnson CA, Morgan NV, Stapelbroek JM, Forshew T, Cooper WN, McKiernan PJ, Klomp LW, Morris AA, Wraith JE, McClean P, Lynch SA, Thompson RJ, Lo B, Quarrell OW, Di Rocco M, Trembath RC, Mandel H, Wali S, Karet FE, Knisely AS, Houwen RH, Kelly DA, Maher ER: Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. Nat Genet. 2004, 36 (4): 400-404. 10.1038/ng1325.CrossRefPubMed

Cullinane AR, Straatman-Iwanowska A, Zaucker A, Wakabayashi Y, Bruce CK, Luo G, Rahman F, Gurakan F, Utine E, Ozkan TB, Denecke J, Vukovic J, Di Rocco M, Mandel H, Cangul H, Matthews RP, Thomas SG, Rappoport JZ, Arias IM, Wolburg H, Knisely AS, Kelly DA, Muller F, Maher ER, Gissen P: Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization. Nat Genet. 2010, 42 (4): 303-312. 10.1038/ng.538.CrossRefPubMed

Carim L, Sumoy L, Andreu N, Estivill X, Escarceller M: Cloning, mapping and expression analysis of VPS33B, the human orthologue of rat Vps33b. Cytogenet Cell Genet. 2000, 89 (1-2): 92-95. 10.1159/000015571.CrossRefPubMed

Peterson MR, Emr SD: The class C Vps complex functions at multiple stages of the vacuolar transport pathway. Traffic. 2001, 2 (7): 476-486. 10.1034/j.1600-0854.2001.20705.x.CrossRefPubMed

Cullinane AR, Straatman-Iwanowska A, Seo JK, Ko JS, Song KS, Gizewska M, Gruszfeld D, Gliwicz D, Tuysuz B, Erdemir G, Sougrat R, Wakabayashi Y, Hinds R, Barnicoat A, Mandel H, Chitayat D, Fischler B, Garcia-Cazorla A, Knisely AS, Kelly DA, Maher ER, Gissen P: Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome. Hum Mutat. 2009, 30 (2): E330-E337. 10.1002/humu.20900.PubMedCentralCrossRefPubMed

10.

Gissen P, Johnson CA, Gentle D, Hurst LD, Doherty AJ, O'Kane CJ, Kelly DA, Maher ER: Comparative evolutionary analysis of VPS33 homologues: genetic and functional insights. Hum Mol Genet. 2005, 14 (10): 1261-1270. 10.1093/hmg/ddi137.CrossRefPubMed

11.

Zhu GD, Salazar G, Zlatic SA, Fiza B, Doucette MM, Heilman CJ, Levey AI, Faundez V, L'Hernault SW: SPE-39 family proteins interact with the HOPS complex and function in lysosomal delivery. Mol Biol Cell. 2009, 20 (4): 1223-1240. 10.1091/mbc.E08-07-0728.PubMedCentralCrossRefPubMed

12.

Tornieri K, Zlatic SA, Mullin AP, Werner E, Harrison R, L'Hernault SW, Faundez V: Vps33b pathogenic mutations preferentially affect VIPAS39/SPE-39-positive endosomes. Hum Mol Genet. 2013, 22 (25): 5215-5228. 10.1093/hmg/ddt378.PubMedCentralCrossRefPubMed

13.

Ishii A, Kamimori K, Hiyoshi M, Kido H, Ohta T, Konishi H: Inhibitory effect of SPE-39 due to tyrosine phosphorylation and ubiquitination on the function of Vps33B in the EGF-stimulated cells. Febs Lett. 2012, 586 (16): 2245-2250. 10.1016/j.febslet.2012.05.051.CrossRefPubMed

14.

Zlatic SA, Tornieri K, L'Hernault SW, Faundez V: Metazoan cell biology of the HOPS tethering complex. Cell Logist. 2011, 1 (3): 111-117. 10.4161/cl.1.3.17279.PubMedCentralCrossRefPubMed

15.

Matthews RP, Plumb-Rudewiez N, Lorent K, Gissen P, Johnson CA, Lemaigre F, Pack M: Zebrafish vps33b, an ortholog of the gene responsible for human arthrogryposis-renal dysfunction-cholestasis syndrome, regulates biliary development downstream of the onecut transcription factor hnf6. Development. 2005, 132 (23): 5295-5306. 10.1242/dev.02140.CrossRefPubMed

16.

Arhan E, Yusufoglu AM, Sayli TR: Arc syndrome without arthrogryposis, with hip dislocation and renal glomerulocystic appearance: a case report. Eur J Pediatr. 2009, 168 (8): 995-998. 10.1007/s00431-008-0860-5.CrossRefPubMed

17.

Bull LN, Mahmoodi V, Baker AJ, Jones R, Strautnieks SS, Thompson RJ, Knisely AS: VPS33B mutation with ichthyosis, cholestasis, and renal dysfunction but without arthrogryposis: incomplete ARC syndrome phenotype. J Pediatr. 2006, 148 (2): 269-271. 10.1016/j.jpeds.2005.10.005.CrossRefPubMed

18.

Sanseverino MT, de Souza CF, Gissen P, Sordi AO, Magalhaes JA, Schuler-Faccini L: Increased nuchal translucency in arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome and discovery of a Portuguese specific mutation in the VPS33B gene. Ultrasound Obstet Gynecol. 2006, 28 (2): 233-234. 10.1002/uog.2822.CrossRefPubMed

19.

Deal JE, Barratt TM, Dillon MJ: Fanconi syndrome, ichthyosis, dysmorphism, jaundice and diarrhoea–a new syndrome. Pediatr Nephrol. 1990, 4 (4): 308-313. 10.1007/BF00862505.CrossRefPubMed

20.

Malaki M, Mandana R, Ghaffari S: ARC syndrome with complex renal problems: nephrocalcinosis, proximal and hyperkalemic distal RTA and nephrogenic diabetes insipidus. Saudi J Kidney Dis Transpl. 2012, 23 (4): 804-809. 10.4103/1319-2442.98165.CrossRefPubMed

21.

Jang JY, Kim KM, Kim GH, Yu E, Lee JJ, Park YS, Yoo HW: Clinical characteristics and VPS33B mutations in patients with ARC syndrome. J Pediatr Gastroenterol Nutr. 2009, 48 (3): 348-354. 10.1097/MPG.0b013e31817fcb3f.CrossRefPubMed

22.

Eastham KM, McKiernan PJ, Milford DV, Ramani P, Wyllie J, Van'T HW, Lynch SA, Morris AA: ARC syndrome: an expanding range of phenotypes. Arch Dis Child. 2001, 85 (5): 415-420. 10.1136/adc.85.5.415.PubMedCentralCrossRefPubMed

23.

Choi HJ, Lee MW, Choi JH, Moon KC, Koh JK: Ichthyosis associated with ARC syndrome: ARC syndrome is one of the differential diagnoses of ichthyosis. Pediatr Dermatol. 2005, 22 (6): 539-542. 10.1111/j.1525-1470.2005.00135.x.CrossRefPubMed

24.

Franceschini P, Barberis L: Arthrogryposis, renal tubular dysfunction, cholestasis, ichthyosis syndrome (ARCI). Eur J Pediatr. 1997, 156 (1): 78-PubMed

25.

Hershkovitz D, Mandel H, Ishida-Yamamoto A, Chefetz I, Hino B, Luder A, Indelman M, Bergman R, Sprecher E: Defective lamellar granule secretion in arthrogryposis, renal dysfunction, and cholestasis syndrome caused by a mutation in VPS33B. Arch Dermatol. 2008, 144 (3): 334-340.CrossRefPubMed

26.

Flaumenhaft R: Alpha-granules: a story in the making. Blood. 2012, 120 (25): 4908-4909. 10.1182/blood-2012-10-459115.CrossRefPubMed

27.

Saadah OI, Bokhari BE, Alshaeri TM, Jastaniah W: Haematological manifestations of arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome: a case report. Arab J Gastroenterol. 2013, 14 (1): 26-28. 10.1016/j.ajg.2013.01.001.CrossRefPubMed

28.

Lo B, Li L, Gissen P, Christensen H, McKiernan PJ, Ye C, Abdelhaleem M, Hayes JA, Williams MD, Chitayat D, Kahr WH: Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood. 2005, 106 (13): 4159-4166. 10.1182/blood-2005-04-1356.CrossRefPubMed

29.

Urban D, Li L, Christensen H, Pluthero FG, Chen SZ, Puhacz M, Garg PM, Lanka KK, Cummings JJ, Kramer H, Wasmuth JD, Parkinson J, Kahr WH: The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet alpha-granule biogenesis. Blood. 2012, 120 (25): 5032-5040. 10.1182/blood-2012-05-431205.PubMedCentralCrossRefPubMed

30.

Akbar MA, Tracy C, Kahr WH, Kramer H: The full-of-bacteria gene is required for phagosome maturation during immune defense in Drosophila. J Cell Biol. 2011, 192 (3): 383-390. 10.1083/jcb.201008119.PubMedCentralCrossRefPubMed

31.

Smith H, Galmes R, Gogolina E, Straatman-Iwanowska A, Reay K, Banushi B, Bruce CK, Cullinane AR, Romero R, Chang R, Ackermann O, Baumann C, Cangul H, Cakmak CF, Aygun C, Coward R, Dionisi-Vici C, Sibbles B, Inward C, Kim CA, Klumperman J, Knisely AS, Watson SP, Gissen P: Associations among genotype, clinical phenotype, and intracellular localization of trafficking proteins in ARC syndrome. Hum Mutat. 2012, 33 (12): 1656-1664. 10.1002/humu.22155.PubMedCentralCrossRefPubMed

32.

Li LT, Zhao J, Chen R, Wang JS: Two novel VPS33B mutations in a patient with arthrogryposis, renal dysfunction and cholestasis syndrome in mainland China. World J Gastroenterol. 2014, 20 (1): 326-329. 10.3748/wjg.v20.i1.326.PubMedCentralCrossRefPubMed

33.

Kim KM, Kim GH, Park YS, Yoo HW: Aberrant splicing by a mutation, c.403 + 2 T > A, in Korean patients with arthrogryposis-renal-dysfunction-cholestasis syndrome. Pediatr Int. 2011, 53 (4): 609-610. 10.1111/j.1442-200X.2011.03418.x.CrossRefPubMed

34.

Tekin N, Durmus-Aydogdu S, Dinleyici EC, Bor O, Bildirici K, Aksit A: Clinical and pathological aspects of ARC (arthrogryposis, renal dysfunction and cholestasis) syndrome in two siblings. Turk J Pediatr. 2005, 47 (1): 67-70.PubMed

35.

Abu-Sa'Da O, Barbar M, Al-Harbi N, Taha D: Arthrogryposis, renal tubular acidosis and cholestasis (ARC) syndrome: two new cases and review. Clin Dysmorphol. 2005, 14 (4): 191-196. 10.1097/00019605-200510000-00005.CrossRefPubMed

36.

Kim SM, Chang HK, Song JW, Koh H, Han SJ: Agranular platelets as a cardinal feature of ARC syndrome. J Pediatr Hematol Oncol. 2010, 32 (4): 253-258. 10.1097/MPH.0b013e3181c3a8d0.CrossRefPubMed

37.

Jang WY, Cho TJ, Bae JY, Jung HW, Ko JS, Park MS, Yoo WJ, Chung CY, Seo JK, Choi IH: Orthopaedic manifestations of arthrogryposis-renal dysfunction-cholestasis syndrome. J Pediatr Orthop. 2011, 31 (1): 107-112. 10.1097/BPO.0b013e3182032c83.CrossRefPubMed

38.

Dehghani SM, Bahador A, Nikeghbalian S, Salahi H, Geramizadeh B, Malekpour A, Malek-Hosseini SA: Liver transplant in a case of arthrogryposis-renal tubular dysfunction-cholestasis syndrome with severe intractable pruritus. Exp Clin Transplant. 2013, 11 (3): 290-292. 10.6002/ect.2012.0202.CrossRefPubMed

Title: Arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome: from molecular genetics to clinical features
Authors: Yaoyao Zhou
Junfeng Zhang
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Italian Journal of Pediatrics / Issue 1/2014
Electronic ISSN: 1824-7288
DOI: https://doi.org/10.1186/s13052-014-0077-3

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome: from molecular genetics to clinical features

Abstract

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2014

Auxology – an editorial

Late diagnosis of celiac disease in an asymptomatic infant with growth failure

Cytophagic histiocytic panniculitis, hemophagocytic lymphohistiocytosis and undetermined autoimmune disorder: reconciling the puzzle

Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children

Bi-level CPAP does not change central blood flow in preterm infants with respiratory distress syndrome

A prospective study on ambulatory care provided by primary care pediatricians during influenza season